Scott D. Grimes - May 5, 2022 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Director
Signature
/s/ Kirk Somers, Attorney-in-Fact
Stock symbol
CDLX
Transactions as of
May 5, 2022
Transactions value $
-$541,047
Form type
4
Date filed
5/9/2022, 04:09 PM
Previous filing
Apr 21, 2022
Next filing
Jul 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Sale -$266K -7.8K -3.2% $34.14 236K May 5, 2022 Direct F1, F2
transaction CDLX Common Stock Sale -$275K -7.94K -3.37% $34.63 228K May 5, 2022 Direct F1, F3
holding CDLX Common Stock 55.8K May 5, 2022 See Footnote F4
holding CDLX Common Stock 53.1K May 5, 2022 See Footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on March 24, 2022, April 1, 2022 and April 5, 2022 and performance stock units that vested on April 6, 2022.
F2 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $33.37 to $34.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F3 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $34.37 to $35.01, inclusive.
F4 The reportable securities are held by the UTMA Custodial account fbo Pierce Grimes.
F5 The reportable securities are held by the 2013 Scott Grimes GRAT UAD.